Advisory Services Network’s Avadel Pharmaceuticals AVDL Stock Holding History

Advisory Services Network’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-265	Closed	-$4.05K	–	1983
2025 Q3	$4.05K	Buy	+265	New	+$3.45K	﹤0.01%	3605
2025 Q1	–	Sell	-12,041	Closed	-$127K	–	1618
2024 Q4	$127K	Hold	12,041	–	–	﹤0.01%	1513
2024 Q3	$169K	Hold	12,041	–	–	﹤0.01%	1422
2024 Q2	$169K	Buy	+12,041	New	+$196K	﹤0.01%	1422
2024 Q1	–	Sell	-16,285	Closed	-$230K	–	1611
2023 Q4	$230K	Hold	16,285	–	–	0.01%	1209
2023 Q3	$168K	Hold	16,285	–	–	﹤0.01%	1354
2023 Q2	$268K	Buy	+16,285	New	+$212K	0.01%	1165

Other funds holding AVDL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's AVDL Position: Q4 2025 in Review

Advisory Services Network sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 265 shares — an estimated $4.05K sold.

Advisory Services Network first reported a position in AVDL in Q2 2023 and held it in 7 quarters. The position peaked at $268K in Q2 2023. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

Advisory Services Network reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Advisory Services Network sold 265 Avadel Pharmaceuticals shares in Q4 2025, an estimated $4.05K.
Advisory Services Network first reported a position in Avadel Pharmaceuticals in Q2 2023 and held it in 7 quarters.
Advisory Services Network's Avadel Pharmaceuticals position peaked at $268K in Q2 2023.
207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.